Introduction: Obstructive sleep apnoea (OSA) is highly prevalent and there is considerable
evidence supporting an independent association with a wide range of co-morbidities …

Obstructive sleep apnoea (OSA), characterized by recurrent periods of upper airway
obstruction and intermittent hypoxaemia, is prevalent in patients with cardiovascular disease …

ABSTRACT CPAP is considered the gold standard treatment in OSA and is highly
efficacious in controlling OSA symptoms. However, treatment effectiveness is limited …

Considerable evidence is now available of an independent association between obstructive
sleep apnea syndrome (OSAS) and cardiovascular disease. The association is particularly …

Background: Obstructive sleep apnoea syndrome (OSAS) affects an estimated 2–4% of the
middle aged population. Meta-analyses of randomised controlled trials have shown that the …

Obstructive Sleep Apnoea (OSA) is common and characterised by repeated apnoeas and
hypopnoeas while asleep due to collapse of the upper airway. OSA can have a significant …

Obstructive sleep apnea (OSA) is characterized by recurrent episodes of partial (hypopnea)
or complete interruption (apnea) in breathing during sleep due to airway collapse in the oral …

Obstructive sleep apnoea (OSA) is a common disorder and is associated with
cardiovascular disease. Continuous positive airway pressure (CPAP), whilst reducing blood …

Randomised controlled trials (RCTs) of continuous positive airway pressure (CPAP) in
obstructive sleep apnoea (OSA) are time consuming, and their findings often inconclusive or …

The obstructive sleep apnea syndrome (OSAS) is associated with the development/
worsening of cardiovascular disease. OSAS is considered to be an independent risk factor …